Under Cornerstone’s Ownership, Zyflo Asthma Med Repositioned For Growth
This article was originally published in The Pink Sheet Daily
Executive Summary
After completing a reverse merger with Critical Therapeutics last year, Cornerstone has retooled the marketing message for the asthma medication and ramped up commercial support.